Using nanotechnology to improve the therapeutic efficacy of iron chelators [ 2016 - ]

Research Grant

Researchers: Prof Gregory Anderson (Principal investigator) ,  Dr SantRayn Pasricha ,  Prof Guangjun Nie ,  Prof Rachel Codd

Brief description Iron loading disorders (such as thalassaemia) represent an important class of human disease. As part of the treatment for these diseases, the iron needs to be removed and this is often done using iron-binding drugs known as iron chelators. Current chelators are not ideal due to side effects or onerous delivery methods. The goal of this project is to use nanotechnology to develop more effective ways of delivering chelators to improve their effectiveness and reduce toxicity.

Funding Amount $692,769.00

Funding Scheme Project Grants

Notes Standard Project Grant